Brief: Reneo Pharmaceuticals Announces Pricing Of Initial Public Offering
April 8 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC
OFFERING
* SAYS INITIAL PUBLIC OFFERING OF 6.25 MILLION COMMON SHARES
PRICED AT $15.00PER SHARE
Source text for Eikon: ID:nGNX6HL2sP
Further company coverage: RPHM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker